Clinical Trial: Novel Biomarkers for Invasive Aspergillosis

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Novel Biomarkers for Invasive Aspergillosis

Brief Summary: Diagnosis of invasive aspergillosis remains difficult, and is often based on a combination of patient characteristics, radiological and microbiological findings. To data, galactomannan (GM) is the only well-validated biomarker available. However, GM still has its shortcomings. There is therefore a need for new, complementary biomarkers. In this study, two of those tests, bis(methylthio)gliotoxin (bmGT) and a lateral flow device, will be validated in a hematological population, and compare it to GM.